XBPHIGH SIGNALFINANCIAL10-K

XBP completed a major business combination transaction that fundamentally restructured the company, evidenced by an 80% decline in stockholders' equity and significant changes to the corporate structure.

The Business Combination involving the acquisition of BPA (formerly Exela Technologies BPA, LLC) represents a transformative corporate event that has substantially altered XBP's financial profile and risk characteristics. The dramatic reduction in stockholders' equity from $437.1M to $87.3M suggests either significant transaction costs, asset write-downs, or unfavorable deal terms that materially weakened the balance sheet.

Comparing 2026-03-31 vs 2025-03-19View on EDGAR →
FINANCIAL ANALYSIS

XBP's financial position deteriorated markedly following the business combination, with stockholders' equity declining 80% while total liabilities increased 19.6% to $814.8M. The company's asset base contracted 17.1% to $902.1M, though current assets grew modestly and inventory increased 74.6%, potentially indicating operational expansion or integration challenges. The widening net loss and reduced capital expenditure suggest the company is managing cash carefully while absorbing the financial impact of the transformative acquisition.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
-80%
$437.1M→$87.3M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Inventory
Balance Sheet
+74.6%
$6.5M→$11.4M

Inventory surged 74.6% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.

Capital Expenditure
Cash Flow
-45.8%
$2.3M→$1.3M

Capex reduced 45.8% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

R&D Expense
P&L
-33.3%
$900K→$600K

R&D spending cut 33.3% — could signal cost discipline or concerning reduction in innovation investment.

Current Liabilities
Balance Sheet
+29.8%
$248.1M→$322.0M

Current liabilities rose 29.8% — increased short-term obligations, watch current ratio.

Current Assets
Balance Sheet
+24.7%
$192.3M→$239.7M

Current assets grew 24.7% — improving short-term liquidity or inventory/receivables build.

Total Liabilities
Balance Sheet
+19.6%
$681.1M→$814.8M

Liabilities increased 19.6% — monitor debt-to-equity ratio and interest coverage.

Total Assets
Balance Sheet
-17.1%
$1.1B→$902.1M

Total assets contracted 17.1% — asset sales, write-downs, or balance sheet optimization underway.

Accounts Receivable
Balance Sheet
+15.6%
$112.7M→$130.3M

Receivables grew 15.6% — monitor days sales outstanding for collection efficiency.

Net Income
P&L
-11.9%
-$11.0M→-$12.4M

Net income declined 11.9% — review whether driven by operations, interest costs, or non-recurring items.

LANGUAGE CHANGES
NEW — 2026-03-31
PRIOR — 2025-03-19
ADDED
As of March 30, 2026, the Registrant had 11,768,050 shares of common stock outstanding.
Unless otherwise indicated or the context otherwise requires, references in this section to we, our, us, XBP Global , the Company and similar terms are to BPA before the Business Combination (as such terms are defined below), and to XBP Global Holdings, Inc.
DEFINED TERMS Following is a glossary of other abbreviations and acronyms that are found in this Annual Report: BPA means Exela Technologies BPA, LLC, (n/k/a XBP Americas, LLC) collectively with its subsidiaries and affiliates.
Business Combination means the acquisition of BPA by the Company pursuant to a Membership Interest Purchase Agreement dated July 3, 2025.
Common Stock means the common stock of XBP Global Holdings, Inc., par value $0.0001.
+7 more — sign up free →
REMOVED
As of March 18, 2025, the Registrant had 30,362,365 shares of common stock outstanding.
Except where the context otherwise requires or where otherwise indicated, the terms Company , we , us , our , the company, and our business in this Annual Report on Form 10-K refer to XBP Europe Inc.
and its subsidiaries before the Business Combination, and to XBP Europe Holdings, Inc.
and its consolidated subsidiaries following consummation of the Business Combination.
SUMMARY RISK FACTORS Our business is subject to numerous risks and uncertainties, including those described in Part I.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →